Ericolol

This classification denotes a beta-adrenergic blocking agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 38R2P4PIEI. European Medicines Agency schedules Ericolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06599MIG. Ericolol generally arises in the molecular formula C18H24CLNO3. The term ERICOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) ERICOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ericolol under HS 29221980 and SITC 51461. As of Q4 2014, ERICOLOL remains the US FDA Preferred Term for this commodity. Ericolol bears US NLM identifiers UMLS ID C1880546 and NCI Concept Code C65527. SMILES: CLC1CC(OCC(O)CNC(C)(C)C)C(C2=CC(=O)CC2)CC1.